Clinical Trial Update: Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis [EARLY_Phase 1]

View source ↗

Summary

This document reports the completion of a randomized, open-label, multicenter Phase 1 study evaluating ciprofloxacin in severe alcoholic hepatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Cirrhosis
• Alcoholic Hepatitis

Drugs mentioned

• Ciprofloxacin (Ciprofloxacin hydrochloride)

Snippet

Sponsor: University of Helsinki | Conditions: Alcoholic Hepatitis, Alcoholic Cirrhosis | EARLY_Phase 1 | Status: COMPLETED